9 news items
AC Immune and Takeda Sign Exclusive Option and License Agreement for Active Immunotherapy Targeting Amyloid Beta for Alzheimer's Disease
ACIU
TAK
13 May 24
, including artificial intelligence, in our business or other initiatives to restructure our operations will lead to the expected benefits; and other
AC Immune and Takeda Sign Exclusive Option and License Agreement for Active Immunotherapy Targeting Amyloid Beta for Alzheimer's Disease
ACIU
TAK
13 May 24
intelligence, in our business or other initiatives to restructure our operations will lead to the expected benefits; and other factors identified
Takeda Announces FY2023 Full Year Results and FY2024 Outlook, Affirming Commitment to Late-Stage Pipeline Development and Core Operating Profit Margin Expansion
TAK
9 May 24
technologies, including artificial intelligence, in our business or other initiatives to restructure our operations will lead to the expected benefits
Takeda Receives Positive CHMP Opinion For Fruquintinib In Previously Treated Metastatic Colorectal Cancer
TAK
26 Apr 24
Demonstrated Significant Improvements in Overall Survival and Progression Free Survival versus Placebo Plus Best Supportive Care, with Benefit Seen Regardless
Takeda Receives Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer
TAK
26 Apr 24
Placebo Plus Best Supportive Care, with Benefit Seen Regardless of Prior Types of Therapy Received
sha64
TAK
22 Apr 24
to accelerate open innovation in early-stage drug discovery, and toward the creation of start-up companies for the benefit of society
4y48i5p3uszd5g828k8becasmgs7yo
TAK
18 Apr 24
receive non-live vaccines and may receive live vaccines if the benefits outweigh the risks
v0thqv2zixytcvlavcfwzpztg23wf43soqgp64p93d09wresjg
TAK
19 Mar 24
approval for this indication may be contingent upon verification and description of clinical benefit in confirmatory trials. This accelerated approval
emuiqkhe 71a4uvbys5trho8
TAK
26 Feb 24
/
"Takeda's long-term goal for our dengue program has been to make QDENGA broadly available to those at risk who may benefit from immunization. Within the last
- Prev
- 1
- Next